Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II - Wikidata - awgldk - TriplyDB

Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II

Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II

http://www.wikidata.org/entity/Q36821496

about

Type-1 angiotensin receptor signaling in central nervous system myeloid cells is pathogenic during fatal alphavirus encephalitis in mice NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?Superoxide regulation of endothelin-converting enzyme H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells.Abeta-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex.NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts.The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfalls Role for NADPH/NADH oxidase in the modulation of vascular tone.Endosomal Nox2 facilitates redox-dependent induction of NF-kappaB by TNF-alpha.Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries Role of NADPH oxidase in host defense against aspergillosis Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease.An NAD(P)H oxidase regulates growth and transcription in melanoma cells.Recycling of vitamin C by a bystander effect.Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes.Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease.Red wine: A drink to your heart.Volumetric measurement of pericardial adipose tissue from contrast-enhanced coronary computed tomography angiography: a reproducibility study NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?Role of superoxide and thromboxane receptors in acute angiotensin II-induced vasoconstriction of rabbit vessels.Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice.Vascular NAD(P)H oxidases: specific features, expression, and regulation.NADPH oxidase: recent evidence for its role in erectile dysfunction.Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1.Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2 Cerebral vascular effects of reactive oxygen species: recent evidence for a role of NADPH-oxidase.Aldosterone-induced inflammation in the rat heart : role of oxidative stress.Semicarbazide-sensitive amine oxidase: role in the vasculature and vasodilation after in situ inhibition.From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension.Reactive oxygen species-mediated signal transduction in the endothelium.Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration.Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes.Synaptic localization of a functional NADPH oxidase in the mouse hippocampus.Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy.Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants.Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice.

P2860

Q27468826-E4F670DD-EA75-4263-8630-AE26A5B1AA1A Q28072348-EB693D1D-D182-4A3B-B9A1-C42C5A33A9DB Q28145487-F72893D7-0FCE-4A40-8229-AE5512E49D7A Q28365390-2C67D51B-CF54-4791-93AD-F9BCD8975626 Q28582555-1E9CE727-2934-4E3C-BCEE-35CB7041A37C Q31834318-700A3D86-CE94-45CD-8254-CF7C89FFD44E Q33201804-C6441513-FD7A-4EB4-BD77-65053D9A66B0 Q33562191-3BB962D9-9099-4B75-9A9F-B453ADC1E35D Q33632757-0FE4A727-48A2-4512-810E-ACB6B4F8A0A9 Q33692492-C5B9A27D-E21B-44A5-8BBF-9247A410F139 Q33741068-74EA419E-CA17-4AFE-8324-F90736437D98 Q33744942-D75822A9-7DBB-453F-AC3D-E0D31C895F77 Q33864943-E6BE0EB3-371F-41E0-8FEF-7E35EEE99311 Q34064046-D97CB554-40C8-4417-9009-44FD65FC294C Q34127326-2F3AC1A0-31B3-42EB-9CBC-AFCEE319B439 Q34159348-91320953-70BB-4EB8-9644-D9E131DA7105 Q34233390-25B2BC67-B119-4481-BFE3-73A2C21EA313 Q34382219-BC3BAB4A-B200-4DD4-B305-1736F0A27694 Q34479731-594E1362-7774-496E-9025-D5E5433B0600 Q34504802-08C03253-1083-4EF9-8D95-B5309B81826D Q34587141-584A4C9D-9969-40FA-A9A2-01DD19D2E69A Q34766266-2096AE15-E42A-4C2A-A4AF-2F33EB8A5CF8 Q35056975-F44E4894-7104-48CF-BA2A-3497C909B909 Q35083693-7A34C014-71C6-4E7C-B4BE-FC19CBF0C58C Q35175526-FDD0AB75-CDE2-41CC-A56F-A53B766E3AE8 Q35301338-83DA15B2-EB3C-4F87-9825-B836815A3A83 Q35379312-E1D68134-9379-479C-977C-CF13BF96DA65 Q35486123-C850B09E-F452-4F82-8501-D0723B04D3B3 Q35608865-B394B1A4-2C87-45A8-8D29-5547FB1DF540 Q35747797-A45D5185-3BC6-4278-9555-E6BD7D5E69D6 Q35837652-5D717D3C-EBD7-481C-9E96-BF5310A89B44 Q35847323-6771C84D-C98B-43CA-8B95-4CC93DE2ED34 Q35888592-35972DC8-9B55-48C5-9D83-8BB6D80DDE01 Q35896207-44C07E02-1DBE-4091-8892-A08129D66FC3 Q35992729-4F3645D8-EC00-4DDA-9846-056AD88F4899 Q36019900-F7E35F0C-DB50-4565-9362-9532C82C654B Q36051340-5EC17931-860B-4D34-8175-0942F64FA278 Q36052377-E5B34BF1-BC5D-4F10-99D5-FEF7BAE206B0 Q36110067-1AC0A98C-62FE-4291-9F3F-3950F0B4AE79 Q36130821-ABE76A50-6EB3-4E82-96C2-9BC12929790F

P2860

Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II

http://www.wikidata.org/entity/Q36821496

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Localization of a constitutive ...... enhancement by angiotensin II

@en

type

label

Localization of a constitutive ...... enhancement by angiotensin II

@en

prefLabel

Localization of a constitutive ...... enhancement by angiotensin II

@en

P1433

Q36821496-D6A1B8C5-7994-4B60-992B-AEB06CBDAA01

P1476

Q36821496-E8AA8B95-6D3D-4699-AD04-06C45D1F7899

P2093

Q36821496-6707CE0F-50B4-4989-B723-6A8E76689E68

Q36821496-8A987610-421B-44F8-A146-A192B597B665

Q36821496-A330F440-EB99-4F31-A766-53E19C4D5BAE

Q36821496-A7668A4D-0F9B-4306-9CDA-63D5AD2E3B3F

Q36821496-D0B4F202-E7C8-4493-AA04-50CA9EF4B569

Q36821496-D7011D43-162E-4479-9F08-824AE3B887BB

P2860

Q36821496-04072D69-92D5-40D4-97C3-F8F728651028

Q36821496-040E7A66-DDD2-45C9-93B6-56B55CE64676

Q36821496-094E07AF-BAB8-4931-8ABD-DF83B9C306A6

Q36821496-1600A739-AAB4-44A6-BBB2-7C60D39B6B6E

Q36821496-203D202B-F4D3-4C60-BE2A-60470FAE6FE2

Q36821496-22F718D0-F087-480C-A95E-C1396645CB2B

Q36821496-271E1B4D-2533-40FF-850B-F5AAD5BED4DA

Q36821496-2B8BFD30-5709-492B-A158-5475877B2780

Q36821496-2C84D7A0-7A8C-4DAA-950C-3150918A2517

Q36821496-308F62D5-F064-4D5C-B9D2-A51B075CC675

P304

Q36821496-30B2A192-4CAF-464A-8F5D-ACAEBD05C376

P31

Q36821496-3C1FB609-576E-4715-AAFE-BD2C14FD38CE

P356

Q36821496-D19214EF-B78E-4B2B-BD7C-38465D2F5149

P407

Q36821496-BB040F25-7272-4723-9DB1-0E872C2DD538

P433

Q36821496-B3533212-6195-4F5D-8FF9-D11C45ADF380

P478

Q36821496-72FA3051-9085-41A7-9354-BBD5F2730A46

P577

Q36821496-5EB66C4D-ADA1-4F62-87CD-12977BE435F0

P5875

Q36821496-33863BA8-B5E0-4E60-817D-511008770B2E

P698

Q36821496-6996B0C2-98A6-4B3E-9A3F-033ACC609081

P921

Q36821496-A621989B-14E0-4B4B-A913-E57E2EE10BD0

P932

Q36821496-B994EC81-1617-4E94-AEA6-F6A27CBF043C

P356

PNAS.94.26.14483

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Localization of a constitutive ...... enhancement by angiotensin II

@en

P2093

G M Callis

http://www.w3.org/2001/XMLSchema#string

J K Clark

http://www.w3.org/2001/XMLSchema#string

M E Cifuentes-Pagano

http://www.w3.org/2001/XMLSchema#string

M T Quinn

http://www.w3.org/2001/XMLSchema#string

P J Pagano

http://www.w3.org/2001/XMLSchema#string

S M Clark

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic structure, chromosomal localization, start of transcription, and tissue expression of the human p40-phox, a new component of the nicotinamide adenine dinucleotide phosphate-oxidase complex

p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells

Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2

Assembly of the human neutrophil NADPH oxidase involves binding of p67phox and flavocytochrome b to a common functional domain in p47phox.

Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.

The adventitia may be a barrier specific to nitric oxide in rabbit pulmonary artery.

Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.

Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins.

P304

14483-14488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.94.26.14483

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

1997-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13823873

http://www.w3.org/2001/XMLSchema#string

P698

9405639

http://www.w3.org/2001/XMLSchema#string

P921

P932

25029

http://www.w3.org/2001/XMLSchema#string